Need professional-grade analysis? Visit stockanalysis.com
$11.90B
121.61
4,214
N/A
Porton Fine Chemicals Ltd (300363) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY21.79, down 3.28% from the previous close.
Over the past year, 300363 has traded between a low of CNY13.84 and a high of CNY29.41. The stock has gained 57.4% over this period. It is currently 25.9% below its 52-week high.
Porton Fine Chemicals Ltd has a market capitalization of $11.90B, with a price-to-earnings ratio of 121.61.
Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatography, and milling. Porton Pharma Solutions Ltd. was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018. The company was incorporated in 2005 and is headquartered in Chongqing, China.
Side-by-side comparison against top Healthcare peers.